Insider txns (12m)
71
Stock / equity
CVS CVS HEALTH Corp
- Company
- CVS HEALTH Corp
- Security
- Equity
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on record
- 22
- Members of Congress
- 6
- Latest trade on record
- June 26, 2026
CVS (CVS HEALTH Corp) has 71 disclosed insider transactions from 22 insiders in the last 12 months (1 open-market buy, 27 sales, about $441.6M at reported prices) and 8 congressional trades from 5 members of Congress. The most recent disclosure was filed August 5, 2026.
Open-market buys / sales
1 / 27
Congress trades (12m)
8
Distinct filers (12m)
27
Share price
Price and chart by TradingView for CVS HEALTH Corp. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
CVS in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
8 people account for the disclosed buying and selling in CVS over the last 12 months; the most active is ROBBINS LARRY with $317M.
Prices insiders traded at
What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.
▲ Bought▼ SoldAverage reported price that day
Insiders reported 10 open-market trades in CVS since Oct 23, 2024, at prices from $53.70 to $96.28; the most recent was a sale at $93.45 on May 21, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
Clark James DavidAGUIRRE FERNANDO
Clark James David reported 27,606 shares held after the latest filing, against 24,401 at the first on record.
Lobbying spend by quarter
How much has CVS HEALTH Corp reported spending on federal lobbying?
CVS HEALTH Corp reported $1.6M in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders trading CVS
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns. Showing 15 of 22.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director | 10 | 0 | 7 | — | $317.5M | May 21, 2026 |
| CAPOZZI HEIDI B | EVP and Chief People Officer | 7 | 3 | 2 | $4,589 | $858K | April 1, 2026 |
| Clark James David | SVP, Cont & Chief Acct Officer | 5 | 0 | 3 | — | $295K | June 26, 2026 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | 5 | 0 | 3 | — | $7.0M | May 8, 2026 |
| AGUIRRE FERNANDO | Director | 4 | 0 | 2 | — | $3.0M | May 21, 2026 |
| Khichi Samrat S. | EVP, CPO and General Counsel | 4 | 0 | 2 | — | $884K | April 1, 2026 |
| Nelson Steven H | EVP and President, Aetna | 4 | 1 | 1 | $1,289 | $176K | April 1, 2026 |
| Shah Prem S | EVP and Group President | 4 | 0 | 2 | — | $127K | April 1, 2026 |
| Compton-Phillips Amy | EVP, Chief Medical Officer | 3 | 0 | 1 | — | $693K | May 31, 2026 |
| Newman Brian | Director | 3 | 0 | 1 | — | $225K | May 31, 2026 |
| Finucane Anne A. | Director | 3 | 0 | 0 | — | — | May 14, 2026 |
| Joyner J. David | President and CEO | 3 | 0 | 2 | — | $737K | April 1, 2026 |
| Balser Jeffrey R. | Director | 2 | 0 | 0 | — | — | May 14, 2026 |
| BROWN C DAVID II | Director | 2 | 0 | 0 | — | — | May 14, 2026 |
| DECOUDREAUX ALECIA A | Director | 2 | 0 | 0 | — | — | May 14, 2026 |
What kind of transactions these are 5 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| A | Grant or award | 42 | 1,022,801 | $74.0M |
| F | Shares withheld for tax | 17 | 70,356 | $5.6M |
| S | Open-market sale | 9 | 3,819,551 | $359.0M |
| P | Open-market purchase | 4 | 104 | $5,877 |
| D | Sale back to the company | 2 | 32,000 | $3.0M |
What each code means: Form 4 transaction codes.
Members of Congress trading CVS
Members whose periodic transaction reports name this ticker. Amounts are the sums of the ranges as filed.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Lisa C. McClain | Representative (MI, District 9), Republican | 3 | 1 | 2 | $3,003–$45K | October 31, 2025 |
| Dwight Evans | Representative (PA, District 3), Democrat | 2 | 0 | 2 | $2,002–$30K | November 21, 2025 |
| Alan Armstrong | Senator (OK), Republican | 1 | 1 | 0 | $1,001–$15K | March 27, 2026 |
| John Boozman | Senator (AR), Republican | 1 | 1 | 0 | $1,001–$15K | January 29, 2026 |
| Val T. Hoyle | Representative (OR, District 4), Democrat | 1 | 0 | 1 | $1,001–$15K | September 23, 2025 |
| Tommy Tuberville | Senator (AL), Republican | 1 | 0 | 1 | $1,001–$15K | August 26, 2024 |
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Clark James David | Sell F | June 26, 2026 | June 29, 2026 | 3d | 454 | $91 | $41K | Form 4 ↗ | ||
| Newman Brian | Sell F | May 31, 2026 | June 1, 2026 | 1d | 2,478 | $91 | $225K | Form 4 ↗ | ||
| Compton-Phillips Amy | Sell F | May 31, 2026 | June 1, 2026 | 1d | 7,618 | $91 | $693K | Form 4 ↗ | ||
| AGUIRRE FERNANDO | Sell D | May 21, 2026 | May 22, 2026 | 1d | 1,563 | $94 | $146K | Form 4 ↗ | ||
| AGUIRRE FERNANDO | Sell D | May 20, 2026 | May 22, 2026 | 2d | 30,437 | $94 | $2.9M | Form 4 ↗ | ||
| ROBBINS LARRY | Option / conversion S | May 21, 2026 | May 21, 2026 | 0d | 378,000 | $93 | $35.3M | indirectderivative | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 21, 2026 | May 21, 2026 | 0d | 370,462 | $93 | $34.6M | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 20, 2026 | May 21, 2026 | 1d | 800 | $96 | $77K | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 20, 2026 | May 21, 2026 | 1d | 66,881 | $96 | $6.4M | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 20, 2026 | May 21, 2026 | 1d | 152,691 | $95 | $14.5M | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 20, 2026 | May 21, 2026 | 1d | 797,628 | $93 | $74.6M | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 19, 2026 | May 21, 2026 | 2d | 151 | $95 | $14K | indirect | Form 4 ↗ | |
| ROBBINS LARRY | Sell S | May 19, 2026 | May 21, 2026 | 2d | 1,983,387 | $94 | $187.3M | indirect | Form 4 ↗ | |
| Gallina John E | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,448 | $97 | $141K | derivative | Form 4 ↗ | |
| Mahoney Michael F | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,737 | $97 | $169K | derivative | Form 4 ↗ | |
| AGUIRRE FERNANDO | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,563 | $97 | $152K | Form 4 ↗ | ||
| Balser Jeffrey R. | Other A | May 14, 2026 | May 15, 2026 | 1d | 2,058 | $97 | $200K | Form 4 ↗ | ||
| KIRBY J SCOTT | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,447 | $97 | $141K | Form 4 ↗ | ||
| Norwalk Leslie V | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,447 | $97 | $141K | Form 4 ↗ | ||
| SANSONE GUY P | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,447 | $97 | $141K | Form 4 ↗ | ||
| DECOUDREAUX ALECIA A | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,448 | $97 | $141K | derivative | Form 4 ↗ | |
| Finucane Anne A. | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,544 | $97 | $150K | derivative | Form 4 ↗ | |
| BROWN C DAVID II | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,544 | $97 | $150K | Form 4 ↗ | ||
| Shulman Douglas H. | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,448 | $97 | $141K | derivative | Form 4 ↗ | |
| ROBBINS LARRY | Other A | May 14, 2026 | May 15, 2026 | 1d | 1,930 | $97 | $187K | derivative | Form 4 ↗ | |
| Mandadi Tilak | Sell S | May 8, 2026 | May 11, 2026 | 3d | 69,551 | $90 | $6.2M | Form 4 ↗ | ||
| Shah Prem S | Other A | March 31, 2026 | April 2, 2026 | 2d | 161,676 | $72 | $11.6M | derivative | Form 4 ↗ | |
| Shah Prem S | Sell F | April 1, 2026 | April 2, 2026 | 1d | 1,484 | $72 | $108K | Form 4 ↗ | ||
| Shah Prem S | Other A | March 31, 2026 | April 2, 2026 | 2d | 25,062 | $72 | $1.8M | Form 4 ↗ | ||
| Newman Brian | Other A | March 31, 2026 | April 2, 2026 | 2d | 125,748 | $72 | $9.0M | derivative | Form 4 ↗ | |
| Newman Brian | Other A | March 31, 2026 | April 2, 2026 | 2d | 19,493 | $72 | $1.4M | Form 4 ↗ | ||
| Nelson Steven H | Other A | March 31, 2026 | April 2, 2026 | 2d | 143,712 | $72 | $10.3M | derivative | Form 4 ↗ | |
| Nelson Steven H | Sell F | April 1, 2026 | April 2, 2026 | 1d | 2,432 | $72 | $176K | Form 4 ↗ | ||
| Nelson Steven H | Other A | March 31, 2026 | April 2, 2026 | 2d | 22,277 | $72 | $1.6M | Form 4 ↗ | ||
| Mandadi Tilak | Other A | March 31, 2026 | April 2, 2026 | 2d | 143,712 | $72 | $10.3M | derivative | Form 4 ↗ | |
| Mandadi Tilak | Sell F | April 1, 2026 | April 2, 2026 | 1d | 3,634 | $72 | $263K | Form 4 ↗ | ||
| Mandadi Tilak | Other A | March 31, 2026 | April 2, 2026 | 2d | 22,277 | $72 | $1.6M | Form 4 ↗ | ||
| Khichi Samrat S. | Other A | March 31, 2026 | April 2, 2026 | 2d | 80,838 | $72 | $5.8M | derivative | Form 4 ↗ | |
| Khichi Samrat S. | Sell F | April 1, 2026 | April 2, 2026 | 1d | 3,541 | $72 | $257K | Form 4 ↗ | ||
| Khichi Samrat S. | Other A | March 31, 2026 | April 2, 2026 | 2d | 12,531 | $72 | $900K | Form 4 ↗ | ||
| Joyner J. David | Sell F | April 1, 2026 | April 2, 2026 | 1d | 8,029 | $72 | $582K | Form 4 ↗ | ||
| Joyner J. David | Other A | March 31, 2026 | April 2, 2026 | 2d | 86,326 | $72 | $6.2M | Form 4 ↗ | ||
| Compton-Phillips Amy | Other A | March 31, 2026 | April 2, 2026 | 2d | 35,928 | $72 | $2.6M | derivative | Form 4 ↗ | |
| Compton-Phillips Amy | Other A | March 31, 2026 | April 2, 2026 | 2d | 5,569 | $72 | $400K | Form 4 ↗ | ||
| Clark James David | Other A | March 31, 2026 | April 2, 2026 | 2d | 11,976 | $72 | $860K | derivative | Form 4 ↗ | |
| Clark James David | Sell F | April 1, 2026 | April 2, 2026 | 1d | 3,262 | $72 | $236K | Form 4 ↗ | ||
| Clark James David | Other A | March 31, 2026 | April 2, 2026 | 2d | 11,138 | $72 | $800K | Form 4 ↗ | ||
| CAPOZZI HEIDI B | Other A | March 31, 2026 | April 2, 2026 | 2d | 64,670 | $72 | $4.6M | derivative | Form 4 ↗ | |
| CAPOZZI HEIDI B | Sell F | April 1, 2026 | April 2, 2026 | 1d | 1,334 | $72 | $97K | Form 4 ↗ | ||
| CAPOZZI HEIDI B | Other A | March 31, 2026 | April 2, 2026 | 2d | 10,025 | $72 | $720K | Form 4 ↗ | ||
| Gallina John E | Other A | March 19, 2026 | March 20, 2026 | 1d | 582 | $72 | $42K | Form 4 ↗ | ||
| Khichi Samrat S. | Sell F | February 28, 2026 | March 2, 2026 | 2d | 7,886 | $80 | $628K | Form 4 ↗ | ||
| Joyner J. David | Sell F | February 28, 2026 | March 2, 2026 | 2d | 1,944 | $80 | $155K | Form 4 ↗ | ||
| Nelson Steven H | Buy P | January 23, 2025 | January 27, 2026 | 369d | 24 | $54 | $1,289 | lateindirect | Form 4 ↗ | |
| Shah Prem S | Sell F | January 1, 2026 | January 5, 2026 | 4d | 247 | $80 | $20K | Form 4 ↗ | ||
| Clark James David | Sell F | December 1, 2025 | December 2, 2025 | 1d | 220 | $79 | $17K | Form 4 ↗ | ||
| Mandadi Tilak | Sell F | November 30, 2025 | December 2, 2025 | 2d | 6,575 | $80 | $528K | Form 4 ↗ | ||
| FARAH ROGER N | Sell F | November 30, 2025 | December 2, 2025 | 2d | 9,748 | $80 | $783K | Form 4 ↗ | ||
| CAPOZZI HEIDI B | Sell F | November 30, 2025 | December 2, 2025 | 2d | 9,470 | $80 | $761K | Form 4 ↗ | ||
| Shulman Douglas H. | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | Form 4 ↗ | ||
| SANSONE GUY P | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | Form 4 ↗ | ||
| ROBBINS LARRY | Other A | November 20, 2025 | November 21, 2025 | 1d | 2,203 | $76 | $167K | derivative | Form 4 ↗ | |
| Norwalk Leslie V | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | Form 4 ↗ | ||
| Mahoney Michael F | Other A | November 20, 2025 | November 21, 2025 | 1d | 2,022 | $76 | $154K | derivative | Form 4 ↗ | |
| KIRBY J SCOTT | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | Form 4 ↗ | ||
| Finucane Anne A. | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,775 | $76 | $135K | derivative | Form 4 ↗ | |
| Finucane Anne A. | Other A | November 20, 2025 | November 21, 2025 | 1d | 591 | $76 | $45K | Form 4 ↗ | ||
| DECOUDREAUX ALECIA A | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,652 | $76 | $126K | derivative | Form 4 ↗ | |
| BROWN C DAVID II | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,775 | $76 | $135K | Form 4 ↗ | ||
| Balser Jeffrey R. | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,775 | $76 | $135K | Form 4 ↗ | ||
| AGUIRRE FERNANDO | Other A | November 20, 2025 | November 21, 2025 | 1d | 1,800 | $76 | $137K | Form 4 ↗ | ||
| CAPOZZI HEIDI B | Buy P | October 23, 2024 | October 14, 2025 | 356d | 35 | $57 | $1,990 | lateindirect | Form 4 ↗ | |
| CAPOZZI HEIDI B | Buy P | October 2, 2024 | October 14, 2025 | 377d | 10 | $62 | $622 | lateindirect | Form 4 ↗ | |
| CAPOZZI HEIDI B | Buy P | September 9, 2024 | October 14, 2025 | 400d | 35 | $56 | $1,976 | lateindirect | Form 4 ↗ |
Congressional trades
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Tommy Tuberville | Sell | August 26, 2024 | August 5, 2026 | — | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| Alan Armstrong | Buy | March 27, 2026 | July 21, 2026 | 116d | — | — | $1,001–$15K | late | Senate PTR ↗ | |
| Dwight Evans | Sell | November 21, 2025 | May 15, 2026 | 175d | — | — | $1,001–$15K | late | House PTR ↗ | |
| John Boozman | Buy | January 29, 2026 | February 15, 2026 | 17d | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| Dwight Evans | Sell | November 21, 2025 | December 19, 2025 | 28d | — | — | $1,001–$15K | House PTR ↗ | ||
| Lisa C. McClain | Buy | October 30, 2025 | November 21, 2025 | 22d | — | — | $1,001–$15K | spouse | House PTR ↗ | |
| Lisa C. McClain | Sell | October 30, 2025 | November 21, 2025 | 22d | — | — | $1,001–$15K | spouse | House PTR ↗ | |
| Lisa C. McClain | Sell | October 31, 2025 | November 21, 2025 | 21d | — | — | $1,001–$15K | spouse | House PTR ↗ | |
| Val T. Hoyle | Sell | September 23, 2025 | October 10, 2025 | 17d | — | — | $1,001–$15K | spouse | House PTR ↗ |
Related stocks
Tickers traded by the same people who traded CVS, by number of filers in common. It shows overlap in public filings and nothing else.
- MSFT Microsoft Corporation - Common Stock 6 filers in common
- NFLX Netflix, Inc. - Common Stock 5 filers in common
- NVDA NVIDIA Corporation - Common Stock 5 filers in common
- GOOGL Alphabet Inc. - Class A Common Stock 5 filers in common
- JNJ Johnson & Johnson Common Stock 5 filers in common
- PYPL 1/16/26. SP PayPal Holdings, Inc. - Common Stock 5 filers in common
- AAPL Apple Inc. - Common Stock 5 filers in common
- BSX Boston Scientific Corporation Common Stock 5 filers in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- How to read a congressional trade report Owner tells you whose asset it was: the member, the spouse, a dependent child, or held jointly.
- Why congressional trade amounts are ranges There are ten ranges; the lowest is $1,001–$15,000 and the highest is over $50,000,000.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 4 | 6 | October 10, 2025 | May 15, 2026 | House Clerk search |
| Senate eFD, periodic transaction reports | 3 | 3 | February 15, 2026 | August 5, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 48 | 74 | October 14, 2025 | June 29, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.